Full D.C. Appeals Court Expected to Uphold ACA Subsidies

Source: Modern Healthcare

The District of Columbia U.S. Circuit Court of Appeals in Washington on Thursday said the full 11-member court will rehear the controversial case that ruled Americans could not receive subsidies to help pay for plans on federally run health insurance exchanges.

Opponents of the Affordable Care Act greeted the D.C. court's initial ruling with praise, saying the judges upheld the text of the law. The law's supporters, however, argued the court read the text too narrowly and applied an unreasonable and inaccurate interpretation of exchange subsidies.

Much is at stake for consumers with the ruling. Without the subsidies, many would be forced to pay higher, potentially unaffordable monthly premiums. HHS said individuals with federal plans who qualified for the tax credits paid an average of $82 a month in health insurance premiums, down from the $346 monthly premium they would otherwise pay.

The healthcare industry is in a state of flux, new disruptions have altered the landscape, changed the status quo and are providing fresh opportunities and challenges for all industry stakeholders to collaborate and work together like never before.

Attend the FDA/CMS Summit for Payers to initiate the collaboration, with top government and key regulatory bodies working closely with healthcare leadership to join forces and build an open culture of harmonization to provide efficient and affordable healthcare to all patients.

Download the complete event agenda now.

Also, blog readers can save an extra $100 off the current rate when using the code XP1917BLOG - that is $500 in total savings! Register now. 

Specialty Pharmacy Collaboration Summit Limited-Time Special Offer for Health Plans Only!

For a limited-time only, we’re offering health plans a special VIP $595 offer* expiring on Friday, August 22, 2014, to attend IIR’s all-new Specialty Pharmacy Collaboration Summit. To register, email Roxana Siu, Marketing Manager at rsiu@iirusa.com. Be sure to mention code: XP1968HPSOCIAL

Due to increasing healthcare costs brought on by health care reforms and the ACA, specialty pharmacies are critical in determining the sustainability of the specialty pharmacy business model. Payers, providers, pharma manufacturers, and even patients need to partner with specialty pharmacies to help fill the oversight gaps in compliance, manage costs and reimbursements, and to gain access to closed distribution channels. Specialty Pharmacies offer their product management and patient adherence services to address these challenges with minimal cost implications.

Don't miss out on the only event offering you the opportunity to benchmark against other health plans and partner directly with specialty pharmacies and pharma manufacturers.

Download the updated brochure for the full agenda and speaker details.

Plus! With the partnering360 networking tool, easily connect with all key stakeholders in the specialty pharmacy value chain and achieve not only your personal objectives, but also your company's collaborative aims. Available exclusively to registered attendees, you will be able to pre-plan for the event, identify and schedule meetings with potential partners, and foster deeper peer-to-peer engagement via discussions.

Health Plans - don’t miss out on this limited-time $595 offer* to attend the entire conference! This offer expires Friday, August 22, 2014. Be sure to use code: XP1968HPSOCIAL. To register, email Roxana Siu, Marketing Manager at rsiu@iirusa.com.


*$595 Offer Eligibility Rules and Regulations: Offer applies only to Health Plan executives. $595 offer is for the whole conference and expires on August 22, 2014. Tiered pricing is valid through expiration date. New pricing takes effect at specific dates indicated. All fees must be paid in full by expiration date or your price will increase to the next level tier. Offer cannot be applied retroactively to confirmed paid registrants. Offer cannot be combined with any other discounts or promotions. All registrants and guests are subject to IIR approval.